Novartis India Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 11, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	20,514	19,384	25,396	13,958	14,579	13,629
Market Cap Growth	-8.20%	-23.67%	81.95%	-4.26%	6.97%	9.90%
Enterprise Value	14,382	13,471	20,578	8,526	10,036	9,162
Last Close Price	830.85	766.56	982.89	511.81	526.52	486.45
PE Ratio	21.10	19.21	29.81	13.50	-	65.21
PS Ratio	5.90	5.44	7.58	3.69	3.65	3.57
PB Ratio	2.65	2.47	3.41	1.80	2.11	1.92
P/TBV Ratio	2.65	2.47	3.41	1.80	2.11	1.92
P/FCF Ratio	-	25.99	22.40	31.37	38.19	-
P/OCF Ratio	-	25.99	22.40	31.16	37.70	-
EV/Sales Ratio	4.14	3.78	6.14	2.25	2.51	2.40
EV/EBITDA Ratio	15.53	14.97	32.61	13.79	39.13	45.83
EV/EBIT Ratio	15.94	15.05	32.70	14.19	42.22	54.31
EV/FCF Ratio	-	18.07	18.15	19.16	26.29	-
Debt / Equity Ratio	0.01	0.01	0.01	0.03	0.04	0.09
Debt / EBITDA Ratio	0.04	0.06	0.11	0.33	0.72	2.15
Debt / FCF Ratio	-	0.07	0.06	0.48	0.63	-
Asset Turnover	-	0.38	0.35	0.39	0.41	0.37
Inventory Turnover	-	4.72	4.02	3.61	3.39	2.75
Quick Ratio	-	4.83	4.05	3.78	2.65	3.66
Current Ratio	-	5.25	4.45	4.25	3.28	4.55
Return on Equity (ROE)	-	13.19%	11.21%	14.09%	-0.53%	2.92%
Return on Assets (ROA)	-	5.97%	4.12%	3.87%	1.52%	1.01%
Return on Invested Capital (ROIC)	40.63%	43.32%	21.31%	24.34%	9.99%	3.63%
Return on Capital Employed (ROCE)	-	11.10%	8.20%	7.30%	3.20%	2.00%
Earnings Yield	4.74%	5.21%	3.36%	7.41%	-0.26%	1.53%
FCF Yield	-	3.85%	4.46%	3.19%	2.62%	-5.08%
Dividend Yield	3.01%	3.26%	2.54%	1.95%	1.90%	2.06%
Payout Ratio	-	61.18%	137.67%	23.89%	-	118.13%
Buyback Yield / Dilution	-0.01%	-	-	-	-	-
Total Shareholder Return	3.00%	3.26%	2.54%	1.95%	1.90%	2.06%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.